Idera Pharma (IDRA) Tops Q3 EPS by 2c

Idera Pharma (NASDAQ: IDRA) reported Q3 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $323 thousand versus the consensus estimate of $122 thousand.

For earnings history and earnings-related data on Idera Pharma (IDRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c